• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Complications of uveitis: prevalence and risk factors in a series of 398 cases].

作者信息

Prieto-del-Cura M, González-Guijarro J

机构信息

Hospital de La Princesa, Madrid, España.

出版信息

Arch Soc Esp Oftalmol. 2009 Oct;84(10):523-8. doi: 10.4321/s0365-66912009001000007.

DOI:10.4321/s0365-66912009001000007
PMID:19902397
Abstract

OBJECTIVE

To estimate the rate of complications and establish risk factors for their development in patients with uveitis.

METHODS

Prospective study of a cohort of 398 patients (413 eyes) that were reviewed from January 2000 to October 2007 and monitored during a period of at least one month. Demographic data, laterality, course (acute, subacute, chronic), location, diagnosis (idiopathic, infectious, ocular origin, systemic origin, others) and development of complications (cataract, cystoid macular edema, macular complications, retinal complications and others) were evaluated.

RESULTS

After a mean follow-up of 35.2 months (range 1-160), 25% of patients developed one or more of the following complications: cataract 8.5%, macular edema 6.1%, macular complications (epiretinal membranes, choroidal neovascular membranes, macular necrosis) 4.1%, retinal complications (retinal detachment, retinal neovascularization, vitreous hemorrhage, retinal tears, retinal vascular occlusions) 4.1%, glaucoma or ocular hypertension 3.6%, and others 1.5%. Risk factors for development of uveitis complications were chronic course OR 6.37 (3.25-12.47) P <0.0001, bilaterality OR 1.98 (1.03-3.08) P =0.039, subacute course OR 1.94 (0.02-4.08) P=0.08, and panuveitis OR 1,92 (0.99-4.80) P=0.161.

CONCLUSIONS

In our patients, cases involving chronic and bilateral uveitis were more prone to develop complications, with cataracts being the most frequent complication (Arch Soc Esp Oftalmol 2009; 84: 523-528).

摘要

相似文献

1
[Complications of uveitis: prevalence and risk factors in a series of 398 cases].
Arch Soc Esp Oftalmol. 2009 Oct;84(10):523-8. doi: 10.4321/s0365-66912009001000007.
2
Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.非感染性中间葡萄膜炎、后葡萄膜炎或全葡萄膜炎患者的眼部并发症风险。
Ophthalmology. 2016 Mar;123(3):655-62. doi: 10.1016/j.ophtha.2015.10.028. Epub 2015 Dec 19.
3
Retinal complications of juvenile idiopathic arthritis-related uveitis: a microperimetry and optical coherence tomography study.幼年特发性关节炎相关性葡萄膜炎的视网膜并发症:一项微视野计和光学相干断层扫描研究。
Ocul Immunol Inflamm. 2010 Jan;18(1):54-9. doi: 10.3109/09273940903311999.
4
Ocular complications of pediatric uveitis.小儿葡萄膜炎的眼部并发症。
Ophthalmology. 2004 Dec;111(12):2299-306. doi: 10.1016/j.ophtha.2004.06.014.
5
Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis.针对结节病性葡萄膜炎继发的黄斑囊样水肿行玻璃体切除术。
Ophthalmology. 2001 Jun;108(6):1140-4. doi: 10.1016/s0161-6420(01)00558-9.
6
Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis.葡萄膜炎患者的超声乳化白内障摘除及后房型人工晶状体植入术
Am J Ophthalmol. 2001 May;131(5):620-5. doi: 10.1016/s0002-9394(00)00909-0.
7
Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach.采用分级治疗方法治疗免疫恢复性葡萄膜炎患者眼部黄斑并发症的长期结果。
Retina. 2004 Jun;24(3):376-82. doi: 10.1097/00006982-200406000-00007.
8
Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment.针对药物治疗无效的眼部结节病相关玻璃体混浊行玻璃体切割术。
Ocul Immunol Inflamm. 2004 Mar;12(1):35-43. doi: 10.1076/ocii.12.1.35.28070.
9
Phakic patients with cystoid macular edema, retinal periphlebitis, and vitreous inflammation.患有黄斑囊样水肿、视网膜静脉周围炎和玻璃体炎症的有晶状体眼患者。
Arch Ophthalmol. 1998 Aug;116(8):1025-9. doi: 10.1001/archopht.116.8.1025.
10
Complications of chronic cyclitis.
Am J Ophthalmol. 1976 Aug;82(2):277-82. doi: 10.1016/0002-9394(76)90434-7.

引用本文的文献

1
Advances in the management of uveitic cataract: current strategies and emerging perspectives.葡萄膜炎性白内障的治疗进展:当前策略与新观点
Int Ophthalmol. 2025 Aug 21;45(1):343. doi: 10.1007/s10792-025-03695-z.
2
New insights into cataract surgery in patients with uveitis: A detailed review of the current literature.葡萄膜炎患者白内障手术的新见解:当前文献的详细综述
Saudi J Ophthalmol. 2022 Feb 18;36(2):133-141. doi: 10.4103/sjopt.sjopt_147_21. eCollection 2022 Apr-Jun.
3
Systemic contribution of inflammatory mediators to the severity of diabetic and uveitic macular edema.
炎症介质对糖尿病性和葡萄膜炎性黄斑水肿严重程度的全身性影响。
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2695-2705. doi: 10.1007/s00417-021-05149-5. Epub 2021 Mar 12.
4
Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis.继发于非感染性葡萄膜炎的黄斑水肿的功能和解剖学结局的预测因素。
PLoS One. 2019 Jan 24;14(1):e0210799. doi: 10.1371/journal.pone.0210799. eCollection 2019.
5
Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials.方案:玻璃体内注射贝伐单抗(阿瓦斯汀)治疗黄斑水肿的效果:随机对照试验的系统评价
J Res Med Sci. 2012 Dec;17(12):1180-7.
6
Mitochondrial oxidative stress initiates visual loss in sympathetic ophthalmia.线粒体氧化应激引发交感性眼炎的视力丧失。
Jpn J Ophthalmol. 2012 May;56(3):191-7. doi: 10.1007/s10384-012-0132-9. Epub 2012 Apr 3.